Mary Hayes, M.D., who serves as chief of women’s imaging at Radiology Associates of Hollywood, Inc. in Hollywood, Florida, is conducting funded research on the effectiveness of SAVI SCOUT, a medical device that uses radar instead of radiation and wires to help surgeons target tissue during a lumpectomy.
Developed by Cianna Medical, SAVI SCOUT uses a small reflector, which is placed into the breast prior to surgery. The system then detects the reflector using its unique radar signal. This method is believed to optimize tissue removal of the cancer while minimizing the removal of healthy tissue. At the same time, patients' discomfort and anxiety are minimized, and Operating Room on-time starts are enhanced. This improves patient outcomes.
Patients with certain types of breast cancer undergo neoadjuvant treatment with hormonal and/or chemotherapy, with the goal of shrinking tumors prior to definitive surgery. When neoadjuvant therapy is highly effective, the cancerous lesions may resolve and no longer be visualized for targeting, leading to additional pre-operative procedures, more complex and costly magnetic resonance-guided procedures and additional surgical procedures to fully excise the target lesion(s).
To address the needs of these patients, Dr. Hayes is researching the long-term placement of the SAVI SCOUT device up to 365 days prior to definitive surgery. If long-term SCOUT device localization is successful, neoadjuvant therapy patients will be able to avoid some of the common and costly limitations associated with standard wire localization. The use of the SCOUT localization procedure may lead to improved excision of the targeted tumor bed and reduced need for additional operations for margin re-excision, resulting in lower breast cancer treatment costs and improved patient satisfaction.